We're kicking off BioProcess International US West with an unforgettable keynote! We're excited to have industry pioneer Tracy Ryan take the stage to share her incredible journey from fighting for her daughter's life to leading groundbreaking advancements in NK Cell therapy. Her story is one of resilience, innovation, and hope. Learn more about Tracy and the work that NKore Biotherapeutics is doing: https://lnkd.in/eKDzhyWp It's not too late to register! Get 10% off your pass using code LINKEDIN10: https://lnkd.in/eC9Vk6ju
About us
Informa Connect Life Sciences (formerly KNect 365 Life Sciences, IBC Life Sciences and IIR Pharma) provides the industry with opportunities to connect with the right people, ideas, data and technology to fast-track therapeutic developments, maximize commerciality and improve patient outcomes. KNect365 Life Sciences is a global community of Scientists, Executives, Regulators, Technologists and Academics. Covering everything from pharmaceuticals and biopharma to healthcare and wellness, our global and broad market reach touches all the critical points on the pharma value chain from bench to bedside. The deep relationship we have with our customers, coupled with our in depth industry knowledge, allows us to deliver custom solutions and memorable experiences that meet the ever changing needs of our clients. Our unique content and unrivalled networking opportunities play a vital role in moving individuals, companies and the industry forward.
- Website
-
https://informaconnect.com/
External link for Informa Connect Life Sciences
- Industry
- Events Services
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Type
- Public Company
- Specialties
- conferences, courses, scientific information, technological information, business information, custom training, drug discovery events, and biopharmaceutical production events
Locations
-
Primary
2 International Place
26th Floor, Suite 2610
Boston, MA 02110-2601, US
-
P.O. Box 414525
Attn: Customer Service
Boston, MA 02241-4525, US
-
708 Third Avenue
4th Floor
New York, NY 10017, US
-
KNect House
30-32 Mortimer Street
London, W1W 7RE, GB
Employees at Informa Connect Life Sciences
-
Nadine M. Ritter, Ph.D.
Biologics Analytical CMC and Lab Quality R&D to GMP
-
Ellen King
retired at IBC Life Sciences
-
Eric Warner
Marketing Leadership | Demand Generation | Product Management
-
Michael Keenan
Project Manager and Producer at Informa Connect Life Sciences, part of Informa plc
Updates
-
Informa Connect Life Sciences reposted this
More stand out sessions at TIDES USA 2025: 🧬 Realizing the Promise of CRISPR Therapeutics - Dr. Kristy Wood (SVP, Technical Operations at Intellia Therapeutics, Inc.) delivered a compelling keynote on their pioneering work developing potentially curative CRISPR-based therapeutics. Her presentation detailed both in vivo programs using IV-administered CRISPR with proprietary delivery technology for precise gene editing within target tissues, and ex vivo approaches engineering human T cells to combat cancer and autoimmune diseases. The clinical data presented demonstrated remarkable progress toward making CRISPR therapies a reality for patients. 📊 Chromatographic Tools for Oligonucleotide Bioanalysis - Corin Perrin and Philipp Hadwiger from Axolabs presented sophisticated chromatographic approaches advancing the analytical capabilities crucial for oligonucleotide therapeutic development. Their dual-speaker format provided comprehensive insights into both technical implementation and strategic applications of these essential tools. 💉 Innovations in mRNA Manufacturing - Kevin Ou (Aldevron) showcased cutting-edge advancements in mRNA vaccine and therapeutic manufacturing processes. His presentation highlighted how manufacturing innovations are accelerating the development timeline and improving the quality of next-generation RNA-based medicines. 🔬 Biodegradable Lipid Nanoparticles with Tunable Immunogenicity - Dr. Syed Reza (NOF METAL COATINGS GROUP) introduced their novel COATSOME® SS Series of biodegradable lipids designed to address immunogenicity challenges in gene editing and mRNA therapeutics. These innovative lipids remain stable in circulation but break down when triggered by cytosolic stimuli. The presentation included impressive data on cytokine profiles, toxicity metrics, and efficacy across multiple animal models. 🧪 Efficient Large-scale siRNA Manufacturing - Arne Berthelmann (Bachem) standout spotlight presentation showcased enzymatic ligation of short RNA fragments as a promising alternative to conventional linear synthesis methods for siRNA manufacturing. This innovative approach offers significant advantages including higher yields and reduced purification requirements. The case study on a therapeutically relevant siRNA sequence provided valuable benchmarking across different manufacturing technologies, along with comprehensive insights into process control strategies for residual enzyme management. This approach could revolutionize large-scale production of siRNA therapeutics. #GeneticMedicine #CRISPR #mRNA #Oligonucleotides #BioPharmaceuticals #DrugDelivery #Biotechnology #Innovation
-
-
Informa Connect Life Sciences reposted this
Groundbreaking Innovations at TIDES USA 2025: The conference kicked off with cutting-edge discussions that are shaping the future of therapeutic development. Standout Sessions: 🔬 The Science Behind GLP-1 Medicines Dr. Lotte Bjerre Knudsen (Novo Nordisk) delivered a fascinating keynote on GLP-1 receptor agonists like semaglutide, highlighting their expanding applications beyond diabetes to obesity management and potential benefits for inflammation, liver disease, and even Alzheimer's. The brain-mediated mechanisms behind weight loss effects were particularly intriguing! ♻️ Sustainability in Oligonucleotides Dr. Prasad Panzade, Ph.D. (Nitto Avecia) presented compelling strategies for environmental responsibility in oligonucleotide development. From green chemistry principles to biodegradable materials and reduced organic solvents, the industry is making significant strides toward sustainability across the entire product lifecycle. 💊 Cardiovascular Breakthroughs Sam Tsimkas (Ionis Pharmaceuticals, Inc.) provided a comprehensive clinical update on oligonucleotides for cardiovascular disease, showcasing promising advancements in this critical therapeutic area. 🧬 mRNA Therapeutics Innovation Dr. Chunping Xu (TriLink BioTechnologies, part of Maravai LifeSciences) revealed novel modification strategies enhancing mRNA therapeutic performance, demonstrating how these innovations are driving the next generation of treatments. 🔬 RaPID Display Technology Professor HIROAKI SUGA (The University of Tokyo) introduced groundbreaking RaPID display format for discovering pseudo-natural products against intracellular protein targets, opening access to unexplored chemical space with cell membrane permeability of macrocycles. #Biotechnology #Pharmaceuticals #DrugDevelopment #Oligonucleotides #mRNA #Sustainability #Innovation
-
-
Informa Connect Life Sciences reposted this
Calling all market access professionals! 📣 Are you a professional or expert in the global market access space with insights to share? Access Insider is now accepting editorial contributions across a wide spectrum of critical industry topics: • Trade and channel strategies • Regional and global market access hubs • Pharmacy operations and innovations • Specialty pharmacy developments • Patient support and access services • Policy frameworks and changes • Regulatory landscapes and compliance This is your opportunity to showcase your expertise, share best practices, and contribute to meaningful discussions that shape our industry. Be part of our expert network and contribute to shaping the future of market access strategies and solutions. #MarketAccess #PatientAccess Read our guidelines below:
-
Join this complimentary webinar with life sciences experts from CoverMyMeds on June 12th at 12 PM EST, “Dimensionalization of the Patient Journey,” where they will discuss how to truly enhance patient outcomes through collaborative, multi-dimensional strategy. This webinar delves into the practical applications of dimensionalization, a comprehensive approach that incorporates the full spectrum of a patient’s experience to address and help overcome the complexities of medication access. Sign up for this complimentary webinar now: https://lnkd.in/eV3af8hP This discussion will explore key takeaways from the 2025 Medication Access Report: From Barriers to Bridges, including: ✅ Prioritizing data alignment and visibility ✅ Supporting cross-functional collaboration with interoperable tools ✅ Complementing technology with human guidance Click the link below to register! https://lnkd.in/eV3af8hP
-
-
Scenes from the speaker stage on day one of #TIDESUSA We're witnessing unprecedented collaboration in the advancement of oligonucleotide and peptide innovations - creating a powerful ecosystem where industry pioneers are exploring cutting-edge strategies across oligos, peptides, mRNA, and genome editing. These collaborative efforts are transforming therapeutics from promising discoveries to market reality, potentially revolutionizing treatment options for patients worldwide. Who else is excited about the potential of these collaborative approaches to accelerate breakthrough therapies? #Biotechnology #Pharmaceuticals #DrugDiscovery #Oligonucleotides #Peptides #mRNA #GenomeEditing #Collaboration #Innovation #TherapeuticDevelopment
-
-
Who is ready to transform patient access? Join industry leaders from Pfizer, Servier, Cytokinetics and more at Hub and Specialty Pharmacy Models West September 4-5 in San Diego! Problem-solve alongside experts to streamline operations, navigate regulations and enhance patient support programs—all at the stunning Estancia La Jolla Hotel & Spa. Two impactful days. Countless connections. Be sure to register by Friday to save $800: https://lnkd.in/eC5Q2vAg #HubWest2025 #PatientAccess
-
-
Join this complimentary webinar with life sciences experts from Relay Network TOMORROW at 1 PM EST, where they will look at how many reputable pharmaceutical brands are effectively using digital tools to engage patients through every phase of their patient journey, ultimately driving better outcomes. Sign up for this complimentary webinar now: https://lnkd.in/eBVrYbVu Agenda Highlights: ✅ Understand which digital engagement strategies are most effective at different points in the patient journey ✅ Explore how digital tools can support patient coverage navigation and adherence efforts ✅ Gain insights into engagement metrics and industry benchmarks to guide strategy development Digitizing and personalizing the patient experience is table stakes for patient support programs yet remains difficult to execute. Using insights from 34 use cases across 7 therapeutic areas, the session will detail the use cases that move the needle, those that do not, and benchmarks for levels of engagement. Click the link below to register! https://lnkd.in/eBVrYbVu
-
-
Join Industry Leaders at Compounding Pharmacy Compliance 2025! We're excited to welcome Scott Brunner, CAE and Tenille Davis from Alliance for Pharmacy Compounding to our upcoming Compounding Pharmacy Compliance conference in Boston on June 2-3, 2025! As respected voices in pharmacy compounding, Scott and Tenille bring valuable insights on strengthening regulatory frameworks while maintaining flexibility to address patient needs. Their expertise in navigating compliance challenges and advocating for quality standards is essential for compounding professionals staying current with ever-changing regulations. Curious about who else you'll meet? View our current attendee list to see the impressive roster of industry professionals joining us: https://lnkd.in/givPmbHi Don't miss this opportunity to learn from industry leaders who are actively shaping the conversation around compounded medications, quality standards, and patient care. Register now for the preeminent event for compounding professionals: https://lnkd.in/dFRP4KA #PharmacyCompounding #Compliance #RegulatoryAffairs #CompoundingPharmacy #QualityStandards #Networkin
-
-
Join us for a must-attend session at Antibody Engineering & Therapeutics Spring Digital Week: Pfast™ Protein Expression: A Rapid, Robust Solution for Accelerating Biotherapeutic Screening 📅 May 21 | 🕚 11:00 AM EDT | 4:00 PM BST | 5:00 PM CEST 🎙️ Russell Coleman, Director, Strain Engineering, Primrose Bio. Discover how Pfast™, built on 20+ years of Pfenex Expression Technology®, delivers 10-day evaluations of protein titer and quality, helping overcome productivity challenges and streamline your pipeline. 📩 Can’t attend live? Register free to receive on-demand access to all sessions. 👉https://lnkd.in/ez5RssXD #ProteinExpression #Biotherapeutics #AntibodyEngineering #DigitalWeek #BiotechInnovation #AntibodyTherapeutics #Pfenex #PrimroseBio
-